骨桥蛋白与多种肿瘤标志物联合检测在非小细胞肺癌中的研究价值  

Research value of combined detection of osteupontin and multiple tumor markers in non-small cell lung cancer

作　　者：崔丽萍[1] 张锦[1] 

机构地区：[1]宁夏医科大学附属医院呼吸内科,银川750004

出　　处：《国际呼吸杂志》2011年第4期312-315,共4页International Journal of Respiration

摘　　要：肺癌是目前发病率最高的癌症．探讨研究肺癌的肿瘤标志物是当前的热点。骨桥蛋白与非小细胞肺癌的发生、转移及预后关系密切。本文就近几年有关骨桥蛋白与几种肿瘤标志物联合检测非小细胞肺癌的研究进展作一综述。The incidence of lung cancer is the highest amon tumor markers of lung cancer are hol spots al present.It all kinds of cancers currently. The shown close correlation with occurrence, metastasis and prognosis of non-small cell lung cancer. summarizes the current research progress about combined detection of osteopontin and as very article markers in non-small cell lung cancer in recent years.

关 键 词：非小细胞肺癌 肿瘤标志物 骨桥蟹白 CD44 基质金属蛋白酶 血管内皮生长因子 细胞角蛋白19片段 

分 类 号：R734.2[医药卫生—肿瘤]